These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12457768

  • 1. 4D or not 4D - the emetogenic basis of PDE4 inhibitors uncovered?
    Giembycz MA.
    Trends Pharmacol Sci; 2002 Dec; 23(12):548. PubMed ID: 12457768
    [No Abstract] [Full Text] [Related]

  • 2. Chronic obstructive pulmonary disease, inflammation and PDE4 inhibitors.
    Halpin DM.
    Br J Hosp Med (Lond); 2006 Jul; 67(7):370-4. PubMed ID: 16884152
    [No Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 4. Substituted furans as inhibitors of the PDE4 enzyme.
    Perrier H, Bayly C, Laliberté F, Huang Z, Rasori R, Robichaud A, Girard Y, Macdonald D.
    Bioorg Med Chem Lett; 1999 Feb 08; 9(3):323-6. PubMed ID: 10091677
    [Abstract] [Full Text] [Related]

  • 5. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD, Dai YR, Xu ZJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan 08; 27(1):57-9. PubMed ID: 14989829
    [No Abstract] [Full Text] [Related]

  • 6. 7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma.
    Buckley G, Cooper N, Dyke HJ, Galleway F, Gowers L, Gregory JC, Hannah DR, Haughan AF, Hellewell PG, Kendall HJ, Lowe C, Maxey R, Montana JG, Naylor R, Picken CL, Runcie KA, Sabin V, Tuladhar BR, Warneck JB.
    Bioorg Med Chem Lett; 2000 Sep 18; 10(18):2137-40. PubMed ID: 10999488
    [Abstract] [Full Text] [Related]

  • 7. PDE4 inhibitors: new xanthine analogues.
    Montana JG, Cooper N, Dyke HJ, Gowers L, Gregory JP, Hellewell PG, Miotla J, Morris K, Naylor R, Tuladhar B, Warneck JB.
    Bioorg Med Chem Lett; 1998 Oct 20; 8(20):2925-30. PubMed ID: 9873649
    [Abstract] [Full Text] [Related]

  • 8. 8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
    Buckley GM, Cooper N, Dyke HJ, Galleway FP, Gowers L, Haughan AF, Kendall HJ, Lowe C, Maxey R, Montana JG, Naylor R, Oxford J, Peake JC, Picken CL, Runcie KA, Sabin V, Sharpe A, Warneck JB.
    Bioorg Med Chem Lett; 2002 Jun 17; 12(12):1613-5. PubMed ID: 12039574
    [Abstract] [Full Text] [Related]

  • 9. CC-10004 .
    Khobzaoui M, Gutke HJ, Burnet M.
    Curr Opin Investig Drugs; 2005 May 17; 6(5):518-25. PubMed ID: 15912967
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).
    Barnette MS.
    Prog Drug Res; 1999 May 17; 53():193-229. PubMed ID: 10616299
    [Abstract] [Full Text] [Related]

  • 11. Selective PDE4 inhibitors as potent anti-inflammatory drugs for the treatment of airway diseases.
    Lagente V, Martin-Chouly C, Boichot E, Martins MA, Silva PM.
    Mem Inst Oswaldo Cruz; 2005 Mar 17; 100 Suppl 1():131-6. PubMed ID: 15962112
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease.
    Giembycz MA.
    Proc Am Thorac Soc; 2005 Mar 17; 2(4):326-33; discussion 340-1. PubMed ID: 16267357
    [Abstract] [Full Text] [Related]

  • 13. The potential of phosphodiesterase 4 inhibitors for the treatment of depression: opportunities and challenges.
    Renau TE.
    Curr Opin Investig Drugs; 2004 Jan 17; 5(1):34-9. PubMed ID: 14983971
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases.
    Dastidar SG, Rajagopal D, Ray A.
    Curr Opin Investig Drugs; 2007 May 17; 8(5):364-72. PubMed ID: 17520865
    [Abstract] [Full Text] [Related]

  • 15. Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.
    Smith VB, Spina D.
    Curr Opin Investig Drugs; 2005 Nov 17; 6(11):1136-41. PubMed ID: 16312135
    [Abstract] [Full Text] [Related]

  • 16. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
    Celli B.
    Chest; 2006 Jan 17; 129(1):5-6. PubMed ID: 16424403
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors.
    Tait A, Luppi A, Hatzelmann A, Fossa P, Mosti L.
    Bioorg Med Chem; 2005 Feb 15; 13(4):1393-402. PubMed ID: 15670947
    [Abstract] [Full Text] [Related]

  • 18. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
    Kerstjens HA, Timens W.
    Am J Respir Crit Care Med; 2003 Oct 15; 168(8):914-5. PubMed ID: 14555456
    [No Abstract] [Full Text] [Related]

  • 19. 8-Methoxyquinolines as PDE4 inhibitors.
    Billah M, Buckley GM, Cooper N, Dyke HJ, Egan R, Ganguly A, Gowers L, Haughan AF, Kendall HJ, Lowe C, Minnicozzi M, Montana JG, Oxford J, Peake JC, Picken CL, Piwinski JJ, Naylor R, Sabin V, Shih NY, Warneck JB.
    Bioorg Med Chem Lett; 2002 Jun 17; 12(12):1617-9. PubMed ID: 12039575
    [Abstract] [Full Text] [Related]

  • 20. The potential of PDE4 inhibitors in asthma or COPD.
    Spina D.
    Curr Opin Investig Drugs; 2000 Oct 17; 1(2):204-13. PubMed ID: 11249575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.